# CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea

Study · id `cardio:ct-nct06463561` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06463561](<https://clinicaltrials.gov/study/NCT06463561>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06463561

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

## Technical summary

Registry record NCT06463561. Randomized; no masking; primary purpose treatment. Start 2024-07-12 (actual); primary completion 2027-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT06463561, source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)
- Started: 2024-07-12 (actual) (ClinicalTrials.gov record NCT06463561, source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)
- Primary completion: 2027-07-30 (anticipated) (ClinicalTrials.gov record NCT06463561, source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)
- Completion: 2028-01-31 (anticipated) (ClinicalTrials.gov record NCT06463561, source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)
- Countries: Spain (ClinicalTrials.gov record NCT06463561, source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06463561-2024-07-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea
- Acronym: CPAPLIP
- Condition: Sleep Apnea
- Condition: Dyslipidemias
- Condition: Hyperuricemia
- Intervention (Device): Continuous positive airway pressure
- Intervention (Other): Hygienic-dietary recommendations and daily physical activity promotion
- Lead sponsor: Hospital Universitario La Paz
- Lead sponsor class: OTHER
- Collaborator: Hospital Universitario del Henares
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Hospital Universitario La Paz (`cardio:org-hospital-universitario-la-paz`)

## Provenance

Content hash: 974d637a86a5a291dc8669e224f6e82bd7cda75eeef63a9ad2c32394595c1721
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
